GW Pharmaceuticals Plc American Depositary Shares
GWPH
GWPH was delisted on the 4th of May, 2021.
105 hedge funds and large institutions have $930M invested in GW Pharmaceuticals Plc American Depositary Shares in 2015 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 45 increasing their positions, 20 reducing their positions, and 24 closing their positions.
125% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 20
4% less funds holding
Funds holding: 109 → 105 (-4)
17% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 24
24% less capital invested
Capital invested by funds: $1.22B → $930M (-$295M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
66% less call options, than puts
Call options by funds: $48M | Put options by funds: $141M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$13.8M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$13M |
| 3 |
Renaissance Technologies
New York
|
+$11.5M |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$8.58M |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$7.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
-$89.6M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$23.8M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$20.2M |
| 4 |
HCM
Hayman Capital Management
Dallas,
Texas
|
-$19.3M |
| 5 |
Jennison Associates
New York
|
-$17.6M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
126
Brookstone Capital Management
Wheaton,
Illinois
| – | -$5K | -50 | Closed |
|
127
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$5K | -50 | Closed |
|
128
BNP Paribas Financial Markets
Paris,
France
| – | -$91 | -1 | Closed |
|
GWPH Hedge Fund Activity: Q4 2015 in Review
105 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q4 2015, worth a combined $930M — down 24% from $1.22B a quarter earlier.
Sellers outnumbered buyers: 24 funds closed out of GWPH and 20 opened new positions — a net loss of 4 holders — while 20 trimmed existing stakes and 45 added.
The largest buyer was Bank of New York Mellon, adding an estimated $13.8M. The largest seller was OppenheimerFunds, cutting an estimated $89.6M.
- 105 institutional investors held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q4 2015, down from 109 in Q3 2015.
- Funds reported $930M of GW Pharmaceuticals Plc American Depositary Shares stock for Q4 2015, down 24% quarter-over-quarter.
- 20 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q4 2015 and 24 closed out, a net change of -4 holders.
- The largest GW Pharmaceuticals Plc American Depositary Shares buyer in Q4 2015 was Bank of New York Mellon, an estimated $13.8M added.
- The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q4 2015 was OppenheimerFunds, an estimated $89.6M sold.
Based on aggregated 13F filings for Q4 2015.